Clinical Perspectives and Targeted Therapies in Apoptosis: Drug Discovery, Drug Delivery, and Disease Prevention 1st Edition

Clinical Perspectives and Targeted Therapies in Apoptosis: Drug Discovery, Drug Delivery, and Disease Prevention 1st Edition

Clinical Perspectives and Targeted Therapies in Apoptosis: Drug Discovery, Drug Delivery, and Disease Prevention – 1st Edition is a comprehensive, expert‑driven reference that explores the biology, clinical significance, and therapeutic potential of apoptosis (programmed cell death) in health and disease. Edited by Rupinder K. Sodhi and Jitender Madan, and published by Academic Press/Elsevier, this first edition integrates basic science with translational and clinical research, making it valuable for researchers and clinicians in pharmacology, biomedical sciences, drug development, and therapeutic innovation.

📘 Overview

Apoptosis plays a fundamental role in development, tissue homeostasis, and the pathogenesis of many diseases such as cancer, neurodegenerative disorders, autoimmune conditions, and cardiovascular disease. This book begins with core cellular and molecular mechanisms, explaining how apoptotic pathways function and why their dysregulation contributes to disease. It then moves into modern assessment techniques used to quantify apoptosis in research and clinical settings, helping readers understand both basic theory and laboratory application.

🧬 Content Highlights

• Fundamentals of Apoptosis: Detailed discussion of biochemical mechanisms, regulatory proteins, signaling pathways, and physiological consequences of programmed cell death.

• Assessment Methods: Reviews cutting‑edge tools and protocols for measuring apoptosis in vitro and in vivo, including biochemical and imaging‑based assays, which are essential for preclinical research.

• Drug Discovery Applications: Explores how apoptosis plays a central role in identifying drug targets and how apoptosis‑modulating strategies influence the development of new therapeutic agents.

• Drug Delivery and Targeted Therapies: Addresses how novel delivery systems and targeted therapies are designed to modulate apoptosis—improving drug specificity, reducing off‑target effects, and enhancing treatment outcomes.

• Clinical Translation: Includes summaries of apoptosis‑targeting drugs that have reached clinical trials, illustrating how scientific insights are translating into real therapeutic options.

🧠 Why This Book Is Valuable

• Interdisciplinary Approach: Combines cell biology, pharmacology, drug delivery science, and clinical insights, making it relevant for both academic and industrial researchers.

• Clinical Relevance: Emphasizes the role of apoptosis in disease prevention and therapy, showing how apoptotic pathways can be harnessed to treat conditions such as cancer, immune disorders, and degenerative diseases.

• Translational Focus: Balances bench‑side mechanisms with clinical applications, bridging the gap between laboratory research and patient‑centered therapies.

👩‍🔬 Who Should Read This

• Pharmaceutical and biomedical researchers working on novel therapeutics and drug targets

• Clinicians and translational scientists interested in targeted therapies and molecular interventions

• Graduate students and trainees in pharmacology, biotechnology, and medical sciences

• Drug development professionals focusing on apoptosis‑modulating agents

📦 Publication Details

• Editor(s): Rupinder K. Sodhi & Jitender Madan

• Publisher: Academic Press/Elsevier

• First Edition: Circa 2021

• ISBN‑13: 9780128157626

If you’re involved in drug discovery, targeted therapy research, or translational medicine, Clinical Perspectives and Targeted Therapies in Apoptosis offers a solid foundation in both the science of programmed cell death and its therapeutic manipulation, making it an essential addition to your professional library